No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis - a matched pair analysis
Saved in:
Main Authors: | Schmeling Heinrike (Author), Horneff Gerd (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016) -
Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019) -
Etanercept in juvenile idiopathic arthritis: Who will benefit?
by: van den Berg JM, et al.
Published: (2011) -
Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
by: Shantere Ruta, et al.
Published: (2011) -
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
by: Anders Öman, et al.
Published: (2021)